BRKR
Price
$78.56
Change
-$4.38 (-5.28%)
Updated
Apr 18, 6:59 PM EST
14 days until earnings call
WAT
Price
$294.15
Change
-$10.03 (-3.30%)
Updated
Apr 18, 6:59 PM EST
18 days until earnings call
Ad is loading...

Analysis and predictions BRKR vs WAT

Header iconBRKR vs WAT Comparison
Open Charts BRKR vs WATBanner chart's image
Bruker
Price$78.56
Change-$4.38 (-5.28%)
Volume$1.34M
CapitalizationN/A
Waters
Price$294.15
Change-$10.03 (-3.30%)
Volume$200.35K
CapitalizationN/A
View a ticker or compare two or three
BRKR vs WAT Comparison Chart

Loading...

BRKRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
WATDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BRKR vs. WAT commentary
Apr 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRKR is a Hold and WAT is a StrongBuy.

COMPARISON
Comparison
Apr 19, 2024
Stock price -- (BRKR: $82.94 vs. WAT: $304.18)
Brand notoriety: BRKR and WAT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BRKR: 85% vs. WAT: 160%
Market capitalization -- BRKR: $12.93B vs. WAT: $20.38B
BRKR [@Medical Specialties] is valued at $12.93B. WAT’s [@Medical Specialties] market capitalization is $20.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRKR’s FA Score shows that 2 FA rating(s) are green whileWAT’s FA Score has 1 green FA rating(s).

  • BRKR’s FA Score: 2 green, 3 red.
  • WAT’s FA Score: 1 green, 4 red.
According to our system of comparison, BRKR is a better buy in the long-term than WAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRKR’s TA Score shows that 5 TA indicator(s) are bullish while WAT’s TA Score has 3 bullish TA indicator(s).

  • BRKR’s TA Score: 5 bullish, 3 bearish.
  • WAT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BRKR is a better buy in the short-term than WAT.

Price Growth

BRKR (@Medical Specialties) experienced а -6.31% price change this week, while WAT (@Medical Specialties) price change was -9.78% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.86%. For the same industry, the average monthly price growth was -3.97%, and the average quarterly price growth was +9.68%.

Reported Earning Dates

BRKR is expected to report earnings on Aug 01, 2024.

WAT is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Medical Specialties (-3.86% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for BRKR with price predictions.
OPEN
A.I.dvisor published
a Summary for WAT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
WAT($20.4B) has a higher market cap than BRKR($12.9B). BRKR (32.04) and WAT (31.78) have similar P/E ratio . BRKR YTD gains are higher at: 12.940 vs. WAT (-7.609). WAT has higher annual earnings (EBITDA): 1B vs. BRKR (676M). BRKR has more cash in the bank: 488M vs. WAT (396M). BRKR has less debt than WAT: BRKR (1.38B) vs WAT (2.44B). BRKR (2.96B) and WAT (2.96B) have equivalent revenues.
BRKRWATBRKR / WAT
Capitalization12.9B20.4B63%
EBITDA676M1B68%
Gain YTD12.940-7.609-170%
P/E Ratio32.0431.78101%
Revenue2.96B2.96B100%
Total Cash488M396M123%
Total Debt1.38B2.44B57%
FUNDAMENTALS RATINGS
BRKR vs WAT: Fundamental Ratings
BRKR
WAT
OUTLOOK RATING
1..100
5259
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
80
Overvalued
PROFIT vs RISK RATING
1..100
2765
SMR RATING
1..100
2815
PRICE GROWTH RATING
1..100
4654
P/E GROWTH RATING
1..100
8246
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BRKR's Valuation (61) in the Medical Specialties industry is in the same range as WAT (80). This means that BRKR’s stock grew similarly to WAT’s over the last 12 months.

BRKR's Profit vs Risk Rating (27) in the Medical Specialties industry is somewhat better than the same rating for WAT (65). This means that BRKR’s stock grew somewhat faster than WAT’s over the last 12 months.

WAT's SMR Rating (15) in the Medical Specialties industry is in the same range as BRKR (28). This means that WAT’s stock grew similarly to BRKR’s over the last 12 months.

BRKR's Price Growth Rating (46) in the Medical Specialties industry is in the same range as WAT (54). This means that BRKR’s stock grew similarly to WAT’s over the last 12 months.

WAT's P/E Growth Rating (46) in the Medical Specialties industry is somewhat better than the same rating for BRKR (82). This means that WAT’s stock grew somewhat faster than BRKR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BRKRWAT
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
63%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 22 days ago
70%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
53%
View a ticker or compare two or three
Ad is loading...
BRKRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
WATDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JBLU6.830.30
+4.59%
JetBlue Airways Corp
SCI68.51-0.78
-1.13%
Service Corp
PHAT9.80-0.23
-2.29%
Phathom Pharmaceuticals
CMBM3.73-0.18
-4.60%
Cambium Networks Corp
XCUR0.60-0.04
-5.91%
Exicure

BRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRKR has been loosely correlated with A. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if BRKR jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRKR
1D Price
Change %
BRKR100%
-1.13%
A - BRKR
63%
Loosely correlated
-1.64%
WAT - BRKR
60%
Loosely correlated
-3.04%
MTD - BRKR
56%
Loosely correlated
-2.46%
IQV - BRKR
53%
Loosely correlated
-0.82%
RVTY - BRKR
52%
Loosely correlated
+0.27%
More